X-Linked Retinal DysplasiaSymptoms, Doctors, Treatments, Advances & More
X-Linked Retinal Dysplasia Overview
Learn About X-Linked Retinal Dysplasia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Tatsushi Toda practices practicing medicine in Tokyo, Japan. Toda is rated as an Elite expert by MediFind in the treatment of X-Linked Retinal Dysplasia. They are also highly rated in 54 other conditions, according to our data. Their clinical expertise encompasses Walker-Warburg Syndrome, Fukuyama Type Muscular Dystrophy, Lissencephaly, Thrombectomy, and Bone Marrow Transplant.
Keiko Ishigaki practices practicing medicine in Shinjuku, Japan. Ms. Ishigaki is rated as an Elite expert by MediFind in the treatment of X-Linked Retinal Dysplasia. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Walker-Warburg Syndrome, Fukuyama Type Muscular Dystrophy, Lissencephaly, X-Linked Retinal Dysplasia, and Thymectomy.
Takatoshi Sato practices practicing medicine in Shinjuku, Japan. Sato is rated as an Elite expert by MediFind in the treatment of X-Linked Retinal Dysplasia. They are also highly rated in 5 other conditions, according to our data. Their clinical expertise encompasses X-Linked Retinal Dysplasia, Walker-Warburg Syndrome, Fukuyama Type Muscular Dystrophy, Lissencephaly, and Thymectomy.
Summary: Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders and may be associated with autism. Simons Searchlight collects medical, behavioral, learning, and developmental information from people who have these rare genetic changes. The goal of this study is to improve the clinical care and treatment...
Summary: The Congenital Muscle Disease Patient and Proxy Reported Outcome Study (CMDPROS) is a longitudinal 10 year study to identify and trend care parameters, adverse events in the congenital muscle diseases using the Congenital Muscle Disease International Registry (CMDIR) to acquire necessary data for adverse event calculations (intake survey and medical records curation). To support this study and bec...